Literature DB >> 6979578

Modulation of Tac antigen on activated human T cells by anti-Tac monoclonal antibody.

M Tsudo, T Uchiyama, K Takatsuki, H Uchino, J Yodoi.   

Abstract

A monoclonal antibody termed anti-Tac antibody is reactive with activated and functionally mature human T cells, but not reactive with resting T cells or B cells. We found that the expression of Tac antigen on activated T cells was inhibited by the addition of anti-Tac antibody in the culture of T cells activated with Con A or alloantigen. In the mixed lymphocyte culture, the expression of Ia-like antigen on allo-activated T cells was also inhibited by anti-Tac antibody, although the antibody does not recognize Ia-like antigen. However, anti-Ia monoclonal antibody did not suppress the expression of either Tac or Ia-like antigen. In addition, Tac antigen expressed on activated T cells was modulated by anti-Tac antibody cultured with activated T cells at 37 degrees C for 48 hr. Antigenic modulation, which means a specific loss of Tac antigen from the cell surface of T cells, was detected by the indirect immunofluorescence method. Tac antigen was reexpressed on T cells after restimulation when the anti-Tac antibody was removed, whereas Ia-like antigen already expressed on allo-activated T cells was not modulated by anti-Tac antibody. These results suggest that Tac and Ia-like antigens are carried on different molecules, both of which are closely linked in expression on activated T cells. The expression of Tac antigen may be essential for the following expression of Ia-like antigen.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6979578

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  10 in total

1.  The effect of the immunomodulator agent AS101 on interleukin-2 production in systemic lupus erythematosus (SLE) induced in mice by a pathogenic anti-DNA antibody.

Authors:  M Blank; B Sredni; M Albeck; E Mozes; Y Shoenfeld
Journal:  Clin Exp Immunol       Date:  1990-03       Impact factor: 4.330

2.  Partial restoration of impaired interleukin-2 production and Tac antigen (putative interleukin-2 receptor) expression in patients with acquired immune deficiency syndrome by isoprinosine treatment in vitro.

Authors:  K Y Tsang; H H Fudenberg; G M Galbraith; R P Donnelly; L R Bishop; W R Koopmann
Journal:  J Clin Invest       Date:  1985-05       Impact factor: 14.808

3.  Functional and phenotypic comparison of human T cell leukemia/lymphoma virus positive adult T cell leukemia with human T cell leukemia/lymphoma virus negative Sézary leukemia, and their distinction using anti-Tac. Monoclonal antibody identifying the human receptor for T cell growth factor.

Authors:  T A Waldmann; W C Greene; P S Sarin; C Saxinger; D W Blayney; W A Blattner; C K Goldman; K Bongiovanni; S Sharrow; J M Depper
Journal:  J Clin Invest       Date:  1984-06       Impact factor: 14.808

4.  Immunoelectron-microscopic localization of Tac antigen in adult T-cell leukemia/lymphoma.

Authors:  M Shamoto; T Suchi; T Uchiyama
Journal:  Am J Pathol       Date:  1985-06       Impact factor: 4.307

5.  Major-histocompatibility-complex-class-II-positive cells and interleukin-2-dependent proliferation of immune T cells are required to reject carcinoma cells in the guinea pig.

Authors:  P A Steerenberg; W H De Jong; E Geerse; A Beuvink; R J Scheper; W Den Otter; E J Ruitenberg
Journal:  Cancer Immunol Immunother       Date:  1990       Impact factor: 6.968

6.  Transferrin receptor induction in mitogen-stimulated human T lymphocytes is required for DNA synthesis and cell division and is regulated by interleukin 2.

Authors:  L M Neckers; J Cossman
Journal:  Proc Natl Acad Sci U S A       Date:  1983-06       Impact factor: 11.205

7.  Blockade of the interleukin-2 receptor by anti-Tac antibody inhibits the generation of antigen-nonspecific suppressor T cells in vitro.

Authors:  T Oh-Ishi; C K Goldman; J Misiti; T A Waldmann
Journal:  Proc Natl Acad Sci U S A       Date:  1988-09       Impact factor: 11.205

8.  Rat lymphoid cell lines producing human T cell leukemia virus. II. Constitutive expression of rat interleukin 2 receptor.

Authors:  J Yodoi; M Okada; Y Tagaya; K Teshigawara; K Fukui; N Ishida; K Ikuta; M Maeda; T Honjo; H Osawa
Journal:  J Exp Med       Date:  1985-05-01       Impact factor: 14.307

9.  Impact of Infant Thoracic Non-cardiac Perioperative Critical Care on Homotopic-Like Corpus Callosum and Forebrain Sub-regional Volumes.

Authors:  Mackenzie Shea Kagan; Chandler R L Mongerson; David Zurakowski; Dusica Bajic
Journal:  Front Pain Res (Lausanne)       Date:  2022-04-07

Review 10.  The role of the multichain IL-2 receptor complex in the control of normal and malignant T-cell proliferation.

Authors:  T A Waldmann
Journal:  Environ Health Perspect       Date:  1987-11       Impact factor: 9.031

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.